Navigation Links
New Studies Reporting a Higher Incidence of Child Abuse in ADHD and Dyslexia Suggest a Need for Early Medical Treatment, Notes Dr. Harold Levinson

Great Neck, N.Y. (PRWEB) July 22, 2014

Two recent studies indicate that previously untreated adults with dyslexia and ADHD were significantly more abused as children than those without these disorders. And a prior Harvard study noted that stimulant treatment for ADHD children reduces their otherwise higher risk of later addiction and alcohol dependence. However, the data did not reveal causation.

Since over 25% of the population suffer from dyslexia and ADHD, it is imperative to clarify the origins and best treatment for these disorders so as to prevent child abuse and addiction as well as a wide-range of other severe impairments from secondarily arising.

Because Dr. Levinson has examined and successfully treated over 35,000 children and adults with dyslexia and/or ADHD, his clinical insights are considered especially helpful.

Levinson’s four decades of "challenging" research has demonstrated that both ADHD and dyslexia are caused by a primary fine-tuning impairment within the cerebellar-vestibular or “inner-ear” systems— triggering both sensory and motor signal- scrambling.

Accordingly, ADHD occurs when initially normal frontal lobe and related brain mechanisms fail to descramble the distorted concentration and activity signals received and modulated. Similarly, a diverse range of dyslexia symptoms occur when normal parietal and other vital brain structures fail to descramble the “dizzy” reading, writing, spelling and other signals received and transmitted.

Fortunately, there are very favorable therapeutic modalities available for ADHD and/or dyslexia. Were children with the above frequently overlapping disorders properly diagnosed and treated early, both their childhoods and adult lives would be substantially normalized.

"Rapid emotional, behavioral and academic successes often occur when selective combinations of stimulants and related inner-ear-enhancing medications are properly used for ADHD and dyslexia," notes Levinson. "When other slowly helpful modalities are added, they're much more effective and the improvement rate approaches 100%."

By contrast, without vital "normalizing" medical help many dyslexic and ADHD children continue to inwardly feel flawed, dumb, “brainless,” irregardless of IQ. Indeed, the smarter they are the dumber they feel. Prone to increased stress, frustration and repeated failures as well as diminished self-esteem, many feel guilty. As a result, some invite or tolerate punishment and abuse or bullying while others act-out their frustration and anger by abusing others.

Too many of these failing children drift into drugs, attempting to escape their handicap and numb debilitating emotional pain. Their inability to normally function intensifies all other predisposing factors, thereby significantly explaining their higher risks or comorbidity for physical abuse, addiction, depression, anxiety, etc.

Without an in-depth and balanced understanding of the pros and cons of properly prescribed and monitored helpful medications, many caring parents and dedicated individuals may not fully appreciate the remarkable short and long-term benefits possible. And others may naturally fear side-effects and so avoid medication use. However, Levinson’s clinical experience as well as corroborating scientific evidence such as that presented suggest that the risks (e.g., child and drug abuse, etc.) of non-pharmacological treatment for ADHD and dyslexia are greater.

“By analogy, consider medications equivalent to cars, trains and planes,” states Levinson. “When properly maintained and ‘driven,’ benefits are maximized and risks are minimized. If meds are improperly administered and monitored—poorly ‘driven,’ then the fault lies with the prescriber or unsupervised abuser, not the meds.”

“I always start medications, irregardless of their nature, in very low doses, titrate up slowly, and tolerate absolutely no side-effects. A patient's need for steadily increasing doses or non-compliant acting-out is considered a major side-effect. When any negative drug effect initially occurs, they’re often minimal and rapidly disappear as soon as doses or meds are immediately reduced, changed or stopped. As a result, I seldom see significant side-effects--mainly significant benefits."

About Harold Levinson, M.D.:
Formerly Clinical Associate Professor of Psychiatry at New York University Medical Center, Dr. Harold Levinson is currently Director of the Levinson Medical Center for Learning Disabilities in Long Island, New York. He is a well-known neuropsychiatrist, clinical researcher and author. For more information, call 1(800)334-7323 or

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Team studies immune response of Asian elephants infected with a human disease
2. Alzheimers Rate Falling in the United States, Studies Show
3. Eye Tests Might Help ID Alzheimers, Studies Suggest
4. Publishes 64,900 New Studies on Hepatitis C
5. University of Nevada, Reno continues $10 million biomedical studies for COBRE grant
6. Studies: Addiction starts with an overcorrection in the brain
7. Fifty percent of quality improvement studies fail to change medical practices
8. Taking the random out: New approach to medical studies could boost participation
9. Researchers publish one of the longest longitudinal studies of cognition in MS
10. Crescendo Bioscience to present multiple studies at 2014 EULAR Meeting
11. Mount Sinai researchers to present studies at American Society of Clinical Oncology Meeting
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) - Today, ... specializing in both surgical and non-surgical treatments, announced the expansion of his private ... Plastic Surgery. , Highly trained and nationally recognized for his natural approach, ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... provide scholarships for people struggling with eating disorders as a result of the ... second annual event, held at Fox Run Golf Club in Eureka, will help ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... that it has undertaken significant expansion of its current state of the art ... part of PharmaTech’s strategy to increase its manufacturing capacity as well as to ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma Services ... investment of at least $15.8  Million to expand ... Wilmington, NC . The expansion will provide ... meet the growing demands of the pharmaceutical and ... site expansion will provide up to 40,000 square ...
(Date:11/25/2015)...  Henry Schein, Inc., the world,s largest provider of ... and animal health practitioners, will unveil at the Greater ... ConnectDental® Pavilion , which brings together for the first ... to help any practice or laboratory enter the digital ... schedule of experts appearing at the Pavilion. --> ...
Breaking Medicine Technology: